![]() |
|
|
Vol. 296, Issue 2, 426-433, February 2001
Department of Medicine, Cardiovascular Division (Y.G., S.T., S.Z.,
J.A.W.) and Molecular Pharmacology (J.A.W.), Albert Einstein College of
Medicine of Yeshiva University, Bronx, New York
The mitogen-activated protein kinase signaling cascade is used by many
G protein-coupled receptors to initiate functional events. In this
study, activation of the Gq/G11-coupled thromboxane A2 (TxA2) receptor
(TP) by the TxA2 mimetic IBOP in ECV304 cells was found to induce
extracellular regulated kinase (ERK) phosphorylation and tyrosine
phosphorylation of the epidermal growth factor receptor (EGFR), which
were inhibited by the TP antagonist SQ29548, the EGFR kinase inhibitor
AG1478, the Src family kinase inhibitor PP1, the Gi/o protein inhibitor
pertussis toxin (PTX), or the protein kinase C (PKC) inhibitor
calphostin C. TP activation also increased Src kinase activity, which
was blocked by PTX, PP1, and calphostin C, but not by AG1478,
indicating that Src activation occurs before phosphorylation of EGFR.
Blockade of Src activity by expression of dominant negative mutant of
Src inhibits mitogen-activated protein kinase (MAPK) activation induced
by TxA2. ERK activation induced by the PKC activator phorbol myristate
acetate was inhibited by PTX, PP1, AG1478, and calphostin C. In
contrast, activation of ERK by lysophosphatidic acid, a Gi-coupled
receptor activator, was inhibited by PTX, PP1, and AG1478, but not by
calphostin C. Thus, TP-stimulated ERK activation requires Gi, which in
turn requires PKC activation. Immunoprecipitation of G
i showed
increased association of G
i with TP
following PKC activation. In
conclusion, TP
is directly coupled to the Gi protein by a
PKC-regulated mechanism; Gi coupling causes Src-dependent
transactivation of the EGFR, which is the dominant pathway in
TP-mediated ERK activation.
This article has been cited by other articles:
![]() |
O. Moussa, A. W. Ashton, M. Fraig, E. Garrett-Mayer, M. A. Ghoneim, P. V. Halushka, and D. K. Watson Novel Role of Thromboxane Receptors {beta} Isoform in Bladder Cancer Pathogenesis Cancer Res., June 1, 2008; 68(11): 4097 - 4104. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Shineman, B. Zhang, S. N. Leight, D. Pratico, and V. M.-Y. Lee Thromboxane Receptor Activation Mediates Isoprostane-Induced Increases in Amyloid Pathology in Tg2576 Mice J. Neurosci., April 30, 2008; 28(18): 4785 - 4794. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Abdullah, P. L. Pedraza, J. C. McGiff, and N. R. Ferreri CaR activation increases TNF production by mTAL cells via a Gi-dependent mechanism Am J Physiol Renal Physiol, February 1, 2008; 294(2): F345 - F354. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Knock, Y. Shaifta, V. A. Snetkov, B. Vowles, S. Drndarski, J. P.T. Ward, and P. I. Aaronson Interaction between src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery Cardiovasc Res, February 1, 2008; 77(3): 570 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Mukhin, M. Gooz, J. R. Raymond, and M. N. Garnovskaya Collagenase-2 and -3 Mediate Epidermal Growth Factor Receptor Transactivation by Bradykinin B2 Receptor in Kidney Cells J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1033 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yan and H.-H. Tai Glycogen Synthase Kinase-3 Phosphorylation, T-Cell Factor Signaling Activation, and Cell Morphology Change following Stimulation of Thromboxane Receptor {alpha} J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 267 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eligini, F. Violi, C. Banfi, S. S. Barbieri, M. Brambilla, M. Saliola, E. Tremoli, and S. Colli Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism Cardiovasc Res, January 1, 2006; 69(1): 218 - 226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Obara, H. Kurose, and N. Nakahata Thromboxane A2 Promotes Interleukin-6 Biosynthesis Mediated by an Activation of Cyclic AMP-Response Element-Binding Protein in 1321N1 Human Astrocytoma Cells Mol. Pharmacol., September 1, 2005; 68(3): 670 - 679. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Citro, S. Ravasi, G. E. Rovati, and V. Capra Thromboxane Prostanoid Receptor Signals Through Gi Protein to Rapidly Activate Extracellular Signal-Regulated Kinase in Human Airways Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 326 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Braff, M. A. Hawkins, A. D. Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. M. Leung, et al. Structure-Function Relationships among Human Cathelicidin Peptides: Dissociation of Antimicrobial Properties from Host Immunostimulatory Activities J. Immunol., April 1, 2005; 174(7): 4271 - 4278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF] |
||||
![]() |
Q. Zhang, S. M. Thomas, S. Xi, T. E. Smithgall, J. M. Siegfried, J. Kamens, W. E. Gooding, and J. R. Grandis Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells Cancer Res., September 1, 2004; 64(17): 6166 - 6173. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Nair and S. C. Sealfon Agonist-specific Transactivation of Phosphoinositide 3-Kinase Signaling Pathway Mediated by the Dopamine D2 Receptor J. Biol. Chem., November 21, 2003; 278(47): 47053 - 47061. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, R. Vezza, T. Plappert, P. McNamara, J. A. Lawson, S. Austin, D. Pratico, M. S.-J. Sutton, and G. A. FitzGerald COX-2-Dependent Cardiac Failure in Gh/tTG Transgenic Mice Circ. Res., May 30, 2003; 92(10): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. V. Mukhin, E. A. Garnovsky, M. E. Ullian, and M. N. Garnovskaya Bradykinin B2 Receptor Activates Extracellular Signal-Regulated Protein Kinase in mIMCD-3 Cells via Epidermal Growth Factor Receptor Transactivation J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 968 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Buteau, S. Foisy, E. Joly, and M. Prentki Glucagon-Like Peptide 1 Induces Pancreatic {beta}-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor Diabetes, January 1, 2003; 52(1): 124 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Faisy, E. Naline, J.-L. Diehl, X. Emonds-Alt, T. Chinet, and C. Advenier In vitro sensitization of human bronchus by beta 2-adrenergic agonists Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1033 - L1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Miggin and B. T. Kinsella Regulation of Extracellular Signal-Regulated Kinase Cascades by alpha - and beta -Isoforms of the Human Thromboxane A2 Receptor Mol. Pharmacol., April 1, 2002; 61(4): 817 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shizukuda and P. M. Buttrick Protein kinase C-zeta modulates thromboxane A2-mediated apoptosis in adult ventricular myocytes via Akt Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H320 - H327. [Abstract] [Full Text] [PDF] |
||||